miscsubjectsAI governance
Evidence review

PT-141 for Skin: Evidence Review of Effects and Observations

· · 3 min read
bundle · json · system map · manifest

Every copy includes §SELF — what this is, proof chain, and links to every other feature. No context required.

§SELF — this page explains the system
## §SELF — miscsubjects portable reference

**Principle:** Self-explaining payload — no external context required. This _self block describes what you are reading and where to look next.

**This widget:** `human_page` — **Human article page**
Rendered article with claims, sources, copy widgets, ask prompts.
- **article slug:** `pt-141-skin`
- **contains:** rendered article, copy widgets, claims, sources, ask prompts
- **how to use:** Use Copy for LLM or Copy system map — both paste without context.
- **read:** https://miscsubjects.com/a/pt-141-skin

### Logical proof (verify each step)
1. Articles are voxel graphs of tiered claims, not prose blobs. → https://miscsubjects.com/api/articles/constitution
2. Claims link to hash-chained sources via source_ids. → https://miscsubjects.com/api/articles/pt-141-skin/sources
3. Ask reads topology; ingest/claim append to ledger. → https://miscsubjects.com/api/protocol
4. Models queue growth: populate → collaborate → repair → reflex. → https://miscsubjects.com/api/protocol/grow
5. Graph proves its own shape (reflex) and $/claim (yield). → https://miscsubjects.com/graph.html?layer=reflex
6. Full feature index + _explain on every API response. → https://miscsubjects.com/api/articles/system-map

### Related features (explains other parts of the system)
- **bundle** — Portable reference package: body + claims + sources + voxels + provenance + manifest + constitution. · https://miscsubjects.com/api/articles/pt-141-skin/bundle?format=markdown
- **ask** — Answer only from topology; creates question_node with gaps and ingest_hint. · https://miscsubjects.com/api/articles/pt-141-skin/prompts
- **topology** — Claims, sources, anecdotes, user reports, related embeds, question graph slice — for ask/ROUTER. · https://miscsubjects.com/api/articles/pt-141-skin/topology

### Full index
- JSON: https://miscsubjects.com/api/articles/system-map
- Markdown: https://miscsubjects.com/api/articles/system-map?format=markdown

*Not medical advice. Tier-honest. Cite claim/source ids.*

What's breaking down

The body is always doing two things at once: breaking down (degeneration) and building back (regeneration). A condition persists when breakdown outruns repair. Most drugs used for symptoms suppress a signal (pain, acid, anxiety, inflammation) without fixing the tissue that caused the signal. Peptides in this ledger are studied for repair pathways: new blood vessels, repair-cell migration, nerve regrowth, gut lining, neural connections. This article maps one compound through that frame — what it is, how it is proposed to work, what evidence exists, and what people report.

Why PT-141 might help you

  1. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.

How these fit together

Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.

  • PT-141 → sexual / CNS arousal

What the evidence actually shows

This is a count of what is in this ledger — not a claim about all research worldwide.

  • Scientific sources catalogued (PubMed, trials, reviews): 2
  • Claims tagged human evidence: 3
  • Claims tagged preclinical (animal/lab): 0
  • Claims tagged anecdotal: 1
  • Reddit posts catalogued: 1
  • X posts catalogued: 0
  • Other anecdote sources (YouTube, Instagram, etc.): 0
  • Total sources in chain: 3

Quantified confidence (this ledger): 0.43 / 1.00 — low–moderate — mostly preclinical

Formula: human claims×0.12 + preclinical×0.04 + anecdote×0.015 + studies (capped). This is not clinical certainty — it measures how much graded evidence is catalogued here.

What scientists say

Bremelanotide - LiverTox® - NCBI Bookshelf (source s0)

Reviews mechanism and side effects including pigmentation changes from clinical data.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

Bremelanotide Side Effects (source s13)

Details hyperpigmentation rates under daily dosing in studies.

Evidence type: Tagged human evidence in this ledger — check sample size and design.

What people say on Reddit

PT-141 What's the likelihood of permanent skin darkening? — Reddit, r/Peptides (source s14)

User reports of skin darkening after PT-141 initiation.

---

Not medical advice. Counts and quotes are from this article's hash-chained ledger. Anecdote = real reports, not proof. Animal studies ≠ human proof.

Explore this article's relationships

Skin / collagen · condition map

Connected articles

Where this sits in the evidence graph. Open the full interactive map for the whole neighborhood.

Full map →
RelatedPT-141: Brain-Level Arousal · 17 humanPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood… · 8 humanPT-141 for Chemotherapy Side Effects: Evidence on Sexual Arousal Pathw… · 3 humanPT-141 for Diabetic Neuropathy: Evidence-Graded Review · 3 human
Evidence · 3 sources · swipe →chain 1566de26be5b · verify chain · provenance
1 / 3
Evidence ledger 5 · tier-ranked · API
humanlow confidence
Focal hyperpigmentation occurred in about 1% of bremelanotide trial participants using up to 8 doses per month.
sources: s0
humanlow confidence
Daily use for 8 days produced focal hyperpigmentation in 38% of participants in one clinical study.
sources: s13
humanlow confidence
Flushing affected approximately 20% of users in trials.
sources: s0
mechanisticlow confidence
Bremelanotide activates MC1R, which stimulates melanocytes and can increase pigmentation.
sources: s0
anecdotallow confidence
Reddit users describe facial darkening or new moles after PT-141 use.
sources: s14
Model review1 contributions · 1 modelExpand the recursive review layer
1 / 1
grok/grok-4.3writer
redraft2026-06-30 01:08
PT-141 for Skin: Evidence Review of Effects and Observations · 5 claims · 3 sources
inspect — what it was prompted & output
prompted with
(default writer prompt)

input: Write a data-first, evidence-graded article: PT 141 for Skin
Slug: pt-141-skin
Audience: readers researching peptide evidence for this specific condition or drug cross.
Rules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.

ENRICHMENT BRIEF (binding section logic — one ## per compound):
{"voice":"enrichment","article_shape":"single_focus","condition":null,"condition_key":null,"primary_peptide":null,"peptides_in_scope":[{"id":"pt-141","name":"PT-141"}],"drugs_in_scope":[],"weight_sensitive":false,"stimulant_context":false,"breaking_down":{"section_title":"What's breaking down","degenerative_why":[],"degenerative_layers":[],
it output
{
  "slug": "pt-141-skin",
  "title": "PT-141 for Skin: Evidence Review of Effects and Observations",
  "body": "## What's breaking down\n\nSkin tissue can face layers of degeneration where repair pathways lag behind daily wear, UV exposure, inflammation, or hormonal shifts. Pigment cells (melanocytes) may over- or under-respond, leading to uneven tone, spots, or loss of even coloration. Vascular and nerve signals in the skin also influence flushing or localized reactions. When breakdown outpaces natural repair, visible changes persist. PT-141 is discussed in this context because it engages melanocortin pathways that touch both central signaling and peripheral tissue responses.\n\n## Why PT-141 might help you\n\n1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\n\nThe compound acts on melanocortin receptors including MC1R in skin cells. This interaction is studied for its role in melanocyte activity, which relates to pigment production and local tissue responses. If skin pigmentation or repair balance is your concern, the pathway offers a direct mechanistic link rather than symptom suppression alone.\n\n## How these fit together\n\nSingle-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\n- **PT
0246f0f294a2dd01
Machine verification: /api/articles/pt-141-skin/contributions

Latest from the journal

Most recent pieces, site-wide

All articles →
The parts you can't buy yetposted 2026-07-24the-parts-you-cant-buy-yetEveryone Built A Tool Directoryposted 2026-07-24everyone-built-a-tool-directoryIs it LangChain? No. Here's the map.posted 2026-07-24is-it-langchainThe EU AI Act's teeth come in on August 2posted 2026-07-24eu-ai-act-fines-landExport Controls Meet Open Weightsposted 2026-07-24export-controls-meet-open-weights

Related articles

Skin / collagen · condition map

Open evidence map →
PT-141: Brain-Level Arousalpt-141PT-141 and Benzodiazepine Withdrawal: A Data-First Evidence Reviewpt-141-benzo-withdrawalPT-141 and Benzodiazepines: Evidence Review on CNS Arousal Layerspt-141-benzodiazepinesPT-141 (Bremelanotide) and Sexual Dysfunction in the Context of Blood…pt-141-blood-pressure-medsPT-141 for Statin-Associated Cognitive Effects: Evidence Reviewpt-141-brain-fogPT-141 for Carpal Tunnel Syndrome: A Data-First Evidence Reviewpt-141-carpal-tunnel
Ask this article · 8 suggested prompts
topology · JSON · question graph

Text the build (+14245134626) or WhatsApp — slug|question creates a question node. Paste evidence with ingest slug|q:NODE_ID|your paste.

What does the ledger say about this (human tier): "Focal hyperpigmentation occurred in about 1% of bremelanotide trial participants using up to 8 doses per month."?
ask pt-141-skin claim c1 · paste includes §SELF
What does the ledger say about this (human tier): "Daily use for 8 days produced focal hyperpigmentation in 38% of participants in one clinical study."?
ask pt-141-skin claim c2 · paste includes §SELF
What does the ledger say about this (human tier): "Flushing affected approximately 20% of users in trials."?
ask pt-141-skin claim c4 · paste includes §SELF
What does the ledger say about this (mechanistic tier): "Bremelanotide activates MC1R, which stimulates melanocytes and can increase pigmentation."?
ask pt-141-skin claim c3 · paste includes §SELF
What does the ledger say about this (anecdotal tier): "Reddit users describe facial darkening or new moles after PT-141 use."?
ask pt-141-skin claim c5 · paste includes §SELF
Summarize this reddit report and how it should weigh: "User reports of skin darkening after PT-141 initiation."
ask pt-141-skin source s14 · paste includes §SELF
For my medical situation, what can you answer from your catalogue about PT-141 for Skin: Evidence Review of Effects and Observations — and what would you need me to tell you first?
ask pt-141-skin condition gaps · paste includes §SELF
What good and bad outcomes are documented for PT-141 for Skin: Evidence Review of Effects and Observations (studies vs anecdotes)?
ask pt-141-skin good bad experiences · paste includes §SELF
Add your experience or question
Think this article is wrong?
Call bullshit on CharlieOS →
Loading more articles…